Skip to main content
Cary Fu, MD, Child Neurology, Nashville, TN

Cary Fu MD


Assistant Professor at Vanderbilt University

Join to View Full Profile
  • 1161 21st Ave S# A-0118Nashville, TN 37232

  • Phone+1 615-936-0060

  • Fax+1 615-936-0223

Dr. Fu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Cary Fu is a Child Neurologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 12 years. He is experienced in pediatric epilepsy, general child neurology and Rett syndrome.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Clinical Neurophysiology, 2008 - 2009
  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Child Neurology, 2005 - 2008
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2002 - 2005
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2002

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2009 - 2026
  • AL State Medical License
    AL State Medical License 2005 - 2020
  • Neurology with Special Qualification in Child Neurology
    American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • Clinical Neurophysiology
    American Board of Psychiatry and Neurology Clinical Neurophysiology

Publications & Presentations

PubMed

Press Mentions

  • Potential Rett Syndrome Drug Shows Promising Results in Phase 3 Trial
    Potential Rett Syndrome Drug Shows Promising Results in Phase 3 TrialDecember 6th, 2021
  • Rett Syndrome Drug Studied at Vanderbilt Approved for Patients
    Rett Syndrome Drug Studied at Vanderbilt Approved for PatientsJuly 8th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: